ARE 5-HT2 ANTAGONISTS ENDOWED WITH ANXIOLYTIC PROPERTIES IN RODENTS

被引:44
作者
STUTZMANN, JM
EON, B
DARCHE, F
LUCAS, M
RATAUD, J
PIOT, O
BLANCHARD, JC
LADURON, PM
机构
[1] Rhône-Poulenc Rorer, Centre de Recherches de Vitry-Alfortville, Vitry sur Seine
关键词
5-HT2 RECEPTOR ANTAGONIST; ELEVATED PLUS-MAZE TEST; ECOG; ANXIETY;
D O I
10.1016/0304-3940(91)90747-H
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The precise role of serotonin (5-HT) in anxiety remains unclear. We report here on the effects of RP 62203, a new 5-HT2 antagonist, and ritanserin in different animal models of anxiety. In the elevated plus-maze in mice, RP 62203 increased dose-dependently the percentage of entries onto, and time spent on open arms, over the dose range 0.25-4 mg.kg-1 p.o. By contrast, ritanserin was ineffective up to the dose of 4 mg.kg-1 p.o. In addition, both compounds were tested against the anxiogenic compound FG 7142 (20 mg.kg-1, i.p.) in the plus-maze test in mice and via electrocorticographic recordings (ECoG) in rats. The anxiolytic effect of RP 62203 is antagonized by FG 7142 at a dose devoid of anxiogenic properties. A similar interaction between RP 62203 and FG 7142 is observed in ECoG studies. In contrast, ritanserin seemed to potentiate the anxiogenic and awakening activities of FG 7142. These results demonstrate that RP 62203, a selective 5-HT2 antagonist, possesses anxiolytic properties in rodents suggesting that 5-HT2 receptors are involved in the control of anxiety.
引用
收藏
页码:4 / 8
页数:5
相关论文
共 22 条
[1]   EFFECT OF SEROTONERGIC LESION ON ANXIOUS BEHAVIOR MEASURED IN THE ELEVATED PLUS-MAZE TEST IN THE RAT [J].
BRILEY, M ;
CHOPIN, P ;
MORET, C .
PSYCHOPHARMACOLOGY, 1990, 101 (02) :187-189
[2]   SEROTONIN2 AGONIST ADMINISTRATION DOWN-REGULATES RAT-BRAIN SEROTONIN2 RECEPTORS [J].
BUCKHOLTZ, NS ;
ZHOU, DF ;
FREEDMAN, DX .
LIFE SCIENCES, 1988, 42 (24) :2439-2445
[3]   THE INFLUENCE OF RITANSERIN, A SEROTONIN ANTAGONIST, IN ANXIETY DISORDERS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY VERSUS LORAZEPAM [J].
CEULEMANS, DLS ;
HOPPENBROUWERS, MLJA ;
GELDERS, YG ;
REYNTJENS, AJM .
PHARMACOPSYCHIATRY, 1985, 18 (05) :303-305
[4]   ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION [J].
CHOPIN, P ;
BRILEY, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) :383-388
[5]  
CRITCHLEY MAE, 1987, PSYCHOPHARMACOLOGY, V93, P502
[6]  
DECOURCELLES DD, 1985, J BIOL CHEM, V260, P5762
[7]   RP-62203, A NOVEL NAPHTOSULTAM DERIVATIVE WITH POTENT AND SELECTIVE 5HT2 ANTAGONIST PROPERTIES .1. BINDING AND 2ND MESSENGER STUDIES [J].
DOBLE, A ;
ALLAM, D ;
BLANCHARD, JC ;
BOIREAU, A ;
COMTE, MT ;
FARGES, G ;
FERRIS, O ;
GUEREMY, C ;
LADURON, PM ;
MALLERON, JL ;
PERRIER, ML ;
ZUNDEL, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) :1744-1744
[8]  
DOROW R, 1983, LANCET, V2, P98
[9]   5-HT2 RECEPTORS COULD BE PRIMARILY INVOLVED IN THE REGULATION OF SLOW-WAVE SLEEP IN THE RAT [J].
DUGOVIC, C ;
WAUQUIER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 137 (01) :145-146
[10]  
GARDNER CR, 1985, NEUROPHARMACOLOGY SE, P281